These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 30546997)

  • 1. Novel vaccines targeting dendritic cells by coupling allergoids to mannan.
    Benito-Villalvilla C; Soria I; Subiza JL; Palomares O
    Allergo J Int; 2018; 27(8):256-262. PubMed ID: 30546997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel vaccines targeting dendritic cells by coupling allergoids to nonoxidized mannan enhance allergen uptake and induce functional regulatory T cells through programmed death ligand 1.
    Sirvent S; Soria I; Cirauqui C; Cases B; Manzano AI; Diez-Rivero CM; Reche PA; López-Relaño J; Martínez-Naves E; Cañada FJ; Jiménez-Barbero J; Subiza J; Casanovas M; Fernández-Caldas E; Subiza JL; Palomares O
    J Allergy Clin Immunol; 2016 Aug; 138(2):558-567.e11. PubMed ID: 27177779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mite allergoids coupled to nonoxidized mannan from Saccharomyces cerevisae efficiently target canine dendritic cells for novel allergy immunotherapy in veterinary medicine.
    Soria I; Alvarez J; Manzano AI; López-Relaño J; Cases B; Mas-Fontao A; Cañada FJ; Fernández-Caldas E; Casanovas M; Jiménez-Barbero J; Palomares O; Viñals-Flórez LM; Subiza JL
    Vet Immunol Immunopathol; 2017 Aug; 190():65-72. PubMed ID: 28778325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural studies of novel glycoconjugates from polymerized allergens (allergoids) and mannans as allergy vaccines.
    Manzano AI; Javier Cañada F; Cases B; Sirvent S; Soria I; Palomares O; Fernández-Caldas E; Casanovas M; Jiménez-Barbero J; Subiza JL
    Glycoconj J; 2016 Feb; 33(1):93-101. PubMed ID: 26603537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral myeloid cells uptake allergoids coupled to mannan driving Th1/Treg responses upon sublingual delivery in mice.
    Soria I; López-Relaño J; Viñuela M; Tudela JI; Angelina A; Benito-Villalvilla C; Díez-Rivero CM; Cases B; Manzano AI; Fernández-Caldas E; Casanovas M; Palomares O; Subiza JL
    Allergy; 2018 Apr; 73(4):875-884. PubMed ID: 29319882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Dendritic Cells-Targeting Nano-Vaccine by Coupling Polylactic-Co-Glycolic Acid-Encapsulated Allergen with Mannan Induces Regulatory T Cells.
    Wen H; Qu L; Zhang Y; Xu B; Ling S; Liu X; Luo Y; Huo D; Li W; Yao X
    Int Arch Allergy Immunol; 2021; 182(9):777-787. PubMed ID: 34289474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alum impairs tolerogenic properties induced by allergoid-mannan conjugates inhibiting mTOR and metabolic reprogramming in human DCs.
    Benito-Villalvilla C; Soria I; Pérez-Diego M; Fernández-Caldas E; Subiza JL; Palomares O
    Allergy; 2020 Mar; 75(3):648-659. PubMed ID: 31494959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-Type Lectin Receptor Mediated Modulation of T2 Immune Responses to Allergens.
    Angelina A; Martín-Cruz L; de la Rocha-Muñoz A; Lavín-Plaza B; Palomares O
    Curr Allergy Asthma Rep; 2023 Mar; 23(3):141-151. PubMed ID: 36720753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-in-human phase 2 trial with mite allergoids coupled to mannan in subcutaneous and sublingual immunotherapy.
    Nieto A; Mazón Á; Nieto M; Ibáñez E; Jang DT; Calaforra S; Alba P; Pérez-Francés C; Llusar R; Montoro J; de Mateo A; Alamar R; El-Qutob D; Fernández J; Moral L; Toral T; Antón M; Andreu C; Ferrer Á; Flores IM; Cerdá N; Del Pozo S; Caballero R; Subiza JL; Casanovas M
    Allergy; 2022 Oct; 77(10):3096-3107. PubMed ID: 35570712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highlights of Novel Vaccination Strategies in Allergen Immunotherapy.
    Komlósi ZI; Kovács N; Sokolowska M; van de Veen W; Akdis M; Akdis CA
    Immunol Allergy Clin North Am; 2020 Feb; 40(1):15-24. PubMed ID: 31761116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of immune regulation in allergic diseases: the role of regulatory T and B cells.
    Palomares O; Akdis M; Martín-Fontecha M; Akdis CA
    Immunol Rev; 2017 Jul; 278(1):219-236. PubMed ID: 28658547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel immunotherapy vaccine development.
    Jutel M; Akdis CA
    Curr Opin Allergy Clin Immunol; 2014 Dec; 14(6):557-63. PubMed ID: 25304230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot study of immunotherapy in dogs with atopic dermatitis using a mannan-Dermatophagoides farinae allergoid targeting dendritic cells.
    González JL; Zalve V; Fernández-Caldas E; Cases B; Subiza JL; Casanovas M
    Vet Dermatol; 2018 Oct; 29(5):449-e152. PubMed ID: 30183126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances and highlights in allergen immunotherapy: On the way to sustained clinical and immunologic tolerance.
    Berings M; Karaaslan C; Altunbulakli C; Gevaert P; Akdis M; Bachert C; Akdis CA
    J Allergy Clin Immunol; 2017 Nov; 140(5):1250-1267. PubMed ID: 28941667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modified Allergens for Immunotherapy.
    Satitsuksanoa P; Głobińska A; Jansen K; van de Veen W; Akdis M
    Curr Allergy Asthma Rep; 2018 Feb; 18(2):9. PubMed ID: 29450658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New strategies for allergen immunotherapy.
    Carnés J; Robinson DS
    Recent Pat Inflamm Allergy Drug Discov; 2008 Jun; 2(2):92-101. PubMed ID: 19075996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allergen immunotherapy in allergic rhinitis: current use and future trends.
    Klimek L; Pfaar O; Bousquet J; Senti G; Kündig T
    Expert Rev Clin Immunol; 2017 Sep; 13(9):897-906. PubMed ID: 28532268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic effects of dendritic cell targeting and laser-microporation on enhancing epicutaneous skin vaccination efficacy.
    Machado Y; Duinkerken S; Hoepflinger V; Mayr M; Korotchenko E; Kurtaj A; Pablos I; Steiner M; Stoecklinger A; Lübbers J; Schmid M; Ritter U; Scheiblhofer S; Ablinger M; Wally V; Hochmann S; Raninger AM; Strunk D; van Kooyk Y; Thalhamer J; Weiss R
    J Control Release; 2017 Nov; 266():87-99. PubMed ID: 28919557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New approaches to allergen immunotherapy.
    Gunawardana NC; Durham SR
    Ann Allergy Asthma Immunol; 2018 Sep; 121(3):293-305. PubMed ID: 30025907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allergoid-specific T-cell reaction as a measure of the immunological response to specific immunotherapy (SIT) with a Th1-adjuvanted allergy vaccine.
    von Baehr V; Hermes A; von Baehr R; Scherf HP; Volk HD; Fischer von Weikersthal-Drachenberg KJ; Woroniecki S
    J Investig Allergol Clin Immunol; 2005; 15(4):234-41. PubMed ID: 16433203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.